Fifth Third Bancorp
BEAM icon

Fifth Third Bancorp’s Beam Therapeutics BEAM Stock Holding History

Fifth Third Bancorp’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12K Buy
+503
New +$14K ﹤0.01% 3652
2025
Q3 		– Sell
-26
Closed -$442 – 2676
2025
Q2 		$442 Buy
+26
New +$453 ﹤0.01% 2499

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Fifth Third Bancorp's BEAM Position: Q1 2026 in Review

Fifth Third Bancorp opened a new position in Beam Therapeutics (BEAM) in Q1 2026: 503 shares worth $12K. The stake represents ﹤0.01% of the portfolio and ranks #3652 among its holdings. This is a return to the name: Fifth Third Bancorp previously reported a position in BEAM as recently as Q2 2025.

Fifth Third Bancorp first reported a position in BEAM in Q2 2025 and has held it in 2 quarters since. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • Fifth Third Bancorp held 503 shares of Beam Therapeutics worth $12K as of Q1 2026.
  • Beam Therapeutics was a new Fifth Third Bancorp position in Q1 2026.
  • Beam Therapeutics made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q1 2026, its #3652 holding.
  • Fifth Third Bancorp first reported a position in Beam Therapeutics in Q2 2025 and has held it in 2 quarters since.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.